CA41917-1 - 0x000000000000616D

Males & Females of Non-Childbearing Potential


* Stipend may pay up to reflected amount.
Start Date: 
April 29, 2024 - 9:15am
End Date: 
May 16, 2024 - 10:00am

Study Details

Study Number: CA41917
Group Number: 1
Study Requirement: Healthy Normal Male and Female
Stipend: up to £ No search results

Study Criteria

Age: 18 - 55
BMI: 18 - 32
Weight Restriction: minimum weight 0 lbs

Study Information

Indication: This investigational medication is being developed to treat rheumatoid arthritis and pulmonary fibrosis.
Route of Administration: Oral
Blood Draws: 37

Study Schedule

Schedule Type: Long Term
Study Length: 15 Night Stay & 1 Return

Screening Dates:

Event Day Event Date Site
No search results

Doctor Exam Dates:

Event Day Event Date Site
No search results

Study Dates:

Event Type Start Day Start Date End Day End Date Phase Site
Check-In Monday Apr 29 2024 9:15AM Tuesday May 14 2024 10:00AM 1 Belfast
Return Thursday May 16 2024 8:30AM Thursday May 16 2024 10:00AM 1 Belfast